Global Statistics

All countries
549,619,670
Confirmed
Updated on June 28, 2022 2:56 am
All countries
521,350,841
Recovered
Updated on June 28, 2022 2:56 am
All countries
6,351,925
Deaths
Updated on June 28, 2022 2:56 am

Global Statistics

All countries
549,619,670
Confirmed
Updated on June 28, 2022 2:56 am
All countries
521,350,841
Recovered
Updated on June 28, 2022 2:56 am
All countries
6,351,925
Deaths
Updated on June 28, 2022 2:56 am
- Advertisment -

How Many Americans Are Vaccinated For Covid-19

Safety Considerations For Janssen Covid

How many Americans would get a COVID-19 vaccine?

Post-vaccination symptoms

In clinical trials of the Vaccine, pain at the injection site was the most frequently reported local reaction among vaccine recipients erythema and swelling were reported less frequently. Fatigue and headache were the most commonly reported systemic reactions. Most systemic symptoms were mild to moderate in severity and resolved within 12 days. Overall, symptoms were more frequent in people ages 1859 years compared to people ages 60 years and older.

Thrombosis with thrombocytopenia syndrome

TTS is a rare syndrome that includes acute venous or arterial thrombosis and new onset thrombocytopenia in patients with no recent known exposure to heparin. Although the condition is rare, currently available evidence supports a causal relationship between Janssen COVID-19 Vaccine and TTS. Cases of TTS, including deaths, following administration of the Janssen COVID-19 Vaccine have been reported in males and female, with the highest risk in females ages 30-49 years.

Based on an updated risk-benefit analysispdf icon, mRNA COVID-19 vaccines are preferred over the Janssen COVID-19 Vaccine for all vaccine-eligible people. Vaccine providers should start the mRNA COVID-19 vaccine series even if there is uncertainty about how the patient will receive their second dose setting alone should not be a reason to offer the Janssen COVID-19 Vaccine.

However, the Janssen COVID-19 Vaccine may be offered in some situations as described below:

Guillain-Barré syndrome

How Cdc Estimates Vaccination Coverage

CDC estimates the number of people receiving at least one dose, the number of people who are fully vaccinated, and the number of people with a booster dose. CDC estimates are based on data that includes a dose number . To protect the privacy of vaccine recipients, CDC receives data without any personally identifiable information about vaccine doses. Each jurisdiction or provider uses a unique person identifier to link records within their own systems. However, CDC cannot use the unique person identifier to identify individual people by name.

There are challenges in linking doses when someone is vaccinated in different jurisdictions or from different providers. Even with the high-quality data CDC receives from jurisdictions and federal entities, there are limits to how CDC can analyze those data. If a person received doses in more than one jurisdiction or from different providers within the same jurisdiction, they could receive different unique person identifiers for different doses. CDC may not be able to link multiple unique person identifiers for different jurisdictions or providers to a single person.

CDC encourages people to bring their CDC COVID-19 Vaccination Record card with them to their appointment for another COVID-19 vaccine shot because having the card will help ensure the doses are linked.

Looking Ahead: Projected Dates For Vaccination Coverage

Researchers have estimated that around 70% to 85% of the country needs to be immune to the coronavirus for COVID-19 to stop spreading through communities and peter out.

Loading…

People who have recovered from a coronavirus infection may have existing protection against reinfection. However, it’s unclear how strong this natural immunity is and how long it lasts, so public health officials recommend that everyone aged 12 and up get vaccinated against the disease, including those who were previously infected.

Don’t Miss: How Long Does A Cvs Rapid Test Take

I Have A Severe Allergy Can I Get The Mrna Covid

There have been rare cases of people having a severe allergic reaction after receiving the mRNA COVID-19 vaccine. As a result, everyone getting an mRNA vaccine in the US must be observed for at least 15 minutes after getting their shot, so they can receive immediate medical treatment if they experience a severe allergic reaction.

Despite the small risk, most people with a history of severe allergy can safely get the mRNA COVID-19 vaccine. This includes people who are allergic to food, pollen, bee stings, and medications taken by mouth. If you have a history of severe allergy, tell the person administering your vaccine. You will be observed for at least 30 minutes, instead of the usual 15 minutes.

If you have a history of allergic reactions to injectable medications or other vaccines, the CDC recommends asking your doctor if you should get one of the currently available mRNA vaccines.

There are some people who should not get an mRNA COVID vaccine. You should not get one if you are allergic to any components of the mRNA vaccine, which include polyethylene glycol and polysorbate. If you had an allergic reaction within the first 30 minutes after receiving the first vaccine dose, ask your doctor whether or not you should get a second dose. There are different types of allergic reactions and the specifics of your reaction can help inform the decision.

If you have questions regarding the safety of the COVID vaccine for you, your best option is to talk to your doctor.

How We Conducted This Study

Americans are not optimistic that a vaccine for the COVID

To evaluate the impact of the vaccination program in the United States, the researchers expanded their age-stratified, agent-based model of COVID-19 to include waning of naturally acquired or vaccine- elicited immunity, as well as booster vaccination.6,7 For the timelines of this study, the characteristics of three variants were included in the model, each with cumulative prevalence of at least 3 percent in the U.S., including B.1.526 , B.1.1.7 , and B.1.617.2 in addition to the original Wuhan-I SARS-CoV-2 strain.

The model parameters included the population demographics of the U.S., an empirically determined contact network accounting for pandemic mobility patterns, and age-specific risks of severe health outcomes due to COVID-19. The model incorporated data on daily vaccine doses administered in the U.S.8 The minimum age eligibility for vaccination was 16 years before May 13, 2021, after which children 12 to 15 became eligible for vaccination. Vaccination of children ages 5 to 11 with Pfizer-BioNTech started on November 2, 2021.

Vaccine efficacies against infection and symptomatic and severe disease for different vaccine types for each variant and by time since vaccination were drawn from published estimates. The model was calibrated to reported national incidence data between October 1, 2020, and November 30, 2021, and validated with infection, hospitalization, and death trends during the same period.

NOTES

Also Check: Antigen Test At Cvs

Racial And Ethnic Differences

The share of unvaccinated non-Hispanic White adults was not different from the share who were vaccinated. The same was true for Hispanic adults.

But non-Hispanic Black adults were slightly more represented among the unvaccinated than the vaccinated , a small but statistically significant difference.

There were notable differences for the Asian population, however: 6% of the vaccinated were non-Hispanic Asian but only 1% of the unvaccinated were non-Hispanic Asian.

The Us Vaccine Dashboard

Morning Consult is conducting around 30,000 weekly survey interviews in the United States on the vaccine rollout, providing deep insights at a granular level into which segments of the population are most and least opposed to vaccinations, and what factors are driving skepticism. The latest data is based on surveys conducted from May 10-16, 2022, among 32,374 U.S. adults, with a margin of error of 0.5 percentage point. Updates will be provided monthly. Get alerts with the latest data.

Recommended Reading: Cvs Pcr Test For Travel Cost

What Side Effects Can I Expect From The Covid Vaccine

Minor side effects are common after COVID-19 vaccination. Almost everyone experiences arm pain at the injection site. Other symptoms can include low grade fever, body ache, chills, fatigue, and headache.

You can expect to feel better within 24 to 48 hours. Some people feel too unwell to go to work or perform their usually daily activities during this period. Contact your doctor if your symptoms have not improved by the third day.

Moving your sore arm around may help to relieve discomfort. If you have a fever, drink plenty of fluids. Over the counter pain relievers like ibuprofen or acetaminophen can also help with fever, pain, and other discomfort. However, itâs best to not take a pain reliever right before getting your shot, because there is a chance this could blunt your immune response.

The good news: These side effects are a sign that the vaccine is working and that your body is building an antibody response.

States Ranked By Percentage Of Population Fully Vaccinated: Dec 22

Here’s how many Americans have been vaccinated for Covid-19 so far
  • Medium
  • Large

Vermont has the highest percentage of its population fully vaccinated against COVID-19, according to the CDC’s COVID-19 vaccine distribution and administration data tracker.

The CDC’s data tracker compiles data from healthcare facilities and public health authorities. It updates daily to report the total number of people in each state who have been fully vaccinated against COVID-19. The numbers reported by the CDC may vary from the numbers published on individual states’ public health websites, as there may be reporting lags between the states and the CDC.

As of 6 a.m. EDT Dec. 21, a total of 204,578,725 Americans had been fully vaccinated, or 61.6 percent of the country’s population, according to the CDC’s data.

Below are the states and Washington, D.C., ranked by the percentage of their population that has been fully vaccinated against COVID-19, according to the CDC.

1. VermontNumber of people fully vaccinated: 478,502Percentage of population fully vaccinated: 76.68

2. Rhode IslandNumber of people fully vaccinated: 802,940Percentage of population fully vaccinated: 75.79

3. MaineNumber of people fully vaccinated: 1,011,729Percentage of population fully vaccinated: 75.27

4. ConnecticutNumber of people fully vaccinated: 2,644,544Percentage of population fully vaccinated: 74.17

5. MassachusettsNumber of people fully vaccinated: 5,102,236Percentage of population fully vaccinated: 74.03

You May Like: Cvs Testing Cost

Could An Mrna Vaccine Change My Dna

An mRNA vaccine cannot change your DNA.

mRNA, or messenger RNA, is genetic material that contains instructions for making proteins. mRNA vaccines for COVID-19 contain man-made mRNA. Inside the body, the mRNA enters human cells and instructs them to produce the “spike” protein found on the surface of the COVID-19 virus. Soon after a cell makes the spike protein, the cell breaks down the mRNA into harmless pieces. At no point does the mRNA enter the cell’s nucleus, which is where our genetic material lives.

The immune system recognizes the spike protein as an invader and produces antibodies against it. If the antibodies later encounter the actual virus, they are ready to recognize and destroy it before it causes illness.

The two mRNA vaccines available in the US are made by Pfizer/BioNTech and Moderna. Both have been granted full approval by the FDA.

Reporting Of Vaccine Adverse Events

Adverse events that occur in a recipient following COVID-19 vaccination should be reported to VAERS. Vaccination providers are required by FDA to report the following that occur after COVID-19 vaccination under BLA or EUA:

  • Vaccine administration errors
  • Cases of Multisystem Inflammatory Syndrome
  • Cases of COVID-19 that result in hospitalization or death

Reporting is encouraged for any other clinically significant adverse event, even if it is uncertain whether the vaccine caused the event. Information on how to submit a report to VAERS is available at or by calling 1-800-822-7967.

In addition, CDC has developed a new voluntary, smartphone-based tool, v-safe. This tool uses text messaging and web surveys to provide near real-time health check-ins after patients receive COVID-19 vaccination. Reports to v-safe indicating a medically significant health impact, including pregnancy, are followed up by the CDC/v-safe call center to collect additional information to complete a VAERS report, if appropriate.

You May Like: Cost Of Rapid Test At Cvs

Appendix C Vaccine Administration Errors And Deviations

A vaccine administration error is any preventable event that may cause or lead to inappropriate use of vaccine or patient harm.

The FDA-issued Fact Sheet for Healthcare Providers Administering Vaccinesexternal icon should be referenced for detailed information on storage and handling, dosing and schedule, dose preparation, and administration of COVID-19 vaccines. The information provided below on managing vaccine administration errors should not be interpreted as a recommendation or promotion of unauthorized use of the vaccines.

For all vaccine administration errors:

  • For doses recommended to be repeated, some experts suggest delaying the repeat dose for 8 weeks after the invalid dose based on the potential for increased reactogenicity and the rare risk of myocarditis from mRNA COVID-19 vaccine, particularly in groups at increased risk for myocarditis . Individual risk for COVID-19 and the likelihood for an adverse event following COVID-19 vaccination should be taken into consideration when recommending a longer interval. It is acceptable to administer the repeat dose at an interval earlier than 8 weeks as long as the interval is not sooner than the minimal interval noted in Table C: Interim recommendations for COVID-19 vaccine administration errors and deviations.

The recommendations in the table below apply to all FDA-approved or FDA-authorized COVID-19 vaccines and all doses , unless otherwise stated.

  • Pfizer: 1-877-VAX-CO19
  • Moderna: 1-866-MODERNA

The Vaccine Testing Process

Opinion

The development cycle of a vaccine, from lab to clinic.

PRECLINICAL TESTING: Scientists test a new vaccine on cells and then give it to animals such as mice or monkeys to see if it produces an immune response.

PHASE 1 SAFETY TRIALS: Scientists give the vaccine to a small number of people to test safety and dosage, as well as to confirm that it stimulates the immune system.

PHASE 2 EXPANDED TRIALS: Scientists give the vaccine to hundreds of people split into groups, such as children and the elderly, to see if the vaccine acts differently in them. These trials further test the vaccines safety.

PHASE 3 EFFICACY TRIALS: Scientists give the vaccine to thousands of people and wait to see how many become infected, compared with volunteers who received a placebo. These trials can determine if the vaccine protects against the coronavirus, measuring whats known as the efficacy rate. Phase 3 trials are also large enough to reveal evidence of relatively rare side effects.

EARLY OR LIMITED APPROVAL: Many countries have procedures for providing emergency authorizations for vaccines, based on preliminary evidence that they are safe and effective. In addition, some countries such as China and Russia began administering vaccines before detailed Phase 3 trial data was made public. Experts have warned of serious risks from jumping ahead of these results.

emergency use

You May Like: Hank Aaron Dies After Vaccine

Appendix D Schedule Guidance For People Who Are Moderately Or Severely Immunocompromised

D.1. People who are moderately or severely immunocompromised and initiate a Janssen COVID-19 Vaccine primary series

D1. People who are moderately or severely immunocompromised and initiate a Janssen COVID-19 Vaccine primary series

COVID-19 vaccination history
  • Moderna: 0.25mL or 0.5mL , or
No additional vaccinations needed.

*mRNA vaccines are preferred.

See guidance on booster doses for people who are moderately or severely immunocompromised for information on the option of a second booster dose for some people.

When reviewing vaccination history, doses of the Moderna COVID-19 Vaccine received prior to February 7, 2022 should be considered to have been the booster dosage .

D.2. People who are moderately or severely immunocompromised and initiate an mRNA COVID-19 vaccine primary series

D2. People who are moderately or severely immunocompromised and initiate an mRNA COVID-19 vaccine primary series

COVID-19 vaccination history
  • 30-minute observation period: people with history of anaphylaxis
  • 15-minute observation period: all other people

Note: This table is specific to allergy-related contraindications and precautions and is not inclusive of all COVID-19 vaccine contraindications and precautions.

  • Possible anaphylaxis, a progressive life-threatening reaction that typically includes urticaria but also with other symptoms such as wheezing, difficulty breathing, or low blood pressure
  • Any angioedema affecting the airway
  • Diffuse rash which also involves mucosal surfaces

Blocking The Partisan Rhetoric Studying The Science

Last September, Jessica Greenhow, 44, of Eau Claire, Wisc., took a job as an outreach coordinator at the Indianhead Community Action Agency. Part of her job was to educate people about COVID-19 vaccines and help them get to a vaccination site, if they decided they wanted to get the shot. The only problem was that Greenhow wasnt herself vaccinated, and she wasnt comfortable broaching the subject with community members.

I didnt have a problem with people getting the vaccine, she says. But, she didnt want to start a debate about the merits of her own choice. There was a lot of judgmental people and I didnt want to get into it. Its like avoiding a politics conversation or a religious conversationyou didnt want to get in a heated conversation about it.

Read More: Long COVID Patients Are Waiting Months for Care

Republican-leaning counties have had lower vaccination rates than those leaning Democrat since the shots rolled out. Those that are more evenly split have closely followed the national averagesboth in terms of vaccination rate and willingness among the unvaccinated.

The learning process was tedious, she says. When I was starting to do the research on it, many times I was popping up another window, because I had to type in a word to get the definition because I was not understanding anything I was reading, she recalls.

Read Also: Cvs Rapid Testing Price

How Many People In Michigan Have Been Vaccinated So Far

  • 41% of people in Michigan have received at least one dose of the vaccine, for a total of 4,108,622 people
  • 30% of people in Michigan are fully vaccinated, for a total of 2,960,211 people

We pull data on local vaccine distribution on a weekly basis. Check back for our next weekly update mid-week for the latest numbers.

Safe And Happy Holidays

First American to receive COVID-19 vaccine celebrates 1-year milestone

The United States recently surpassed 50 million COVID-19 cases and 800,000 deaths since the start of the pandemic. This week also marks the first anniversary of the first COVID-19 vaccination in the United States. In recent weeks, COVID-19 cases and hospitalizations have increased, with many parts of the country experiencing substantial or high levels of community transmission. These increases and the recent emergence of the Omicron variant highlight the importance of prevention strategies to help people stay safe and reduce the spread of the virus that causes COVID-19.

Although we are still learning about Omicron, weve been fighting COVID-19 since last year and have the tools to end the pandemic. The United States saw the highest peak in COVID-19 cases in January 2021, following the 2020 holiday season. But this year, we have the most important protection of all: vaccination. As people start to travel and gather this year, COVID-19 vaccination, along with other important prevention strategies, continues to be our best defense against severe disease.

Read Also: Cvs Nasal Swab Test

- Advertisment -

Hot Topics

- Advertisment -

Related Articles